Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine
Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine
About this item
Full title
Author / Creator
GUO, ZHONGQIANG , ZHANG, XIAOYU , LI, XUESONG , XIE, FENG , SU, BOXING , ZHANG, MIN and ZHOU, LIQUN
Publisher
Greece: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
Greece: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Prostate cancer is a leading cause of cancer-related death among men. Early diagnosis and treatment are successful against prostate cancer, yet the clinical treatment of advanced prostate cancer remains a challenge. Gemcitabine is used to treat a broad spectrum of solid tumors; however, the clinical response of prostate cancer patients to gemcitabi...
Alternative Titles
Full title
Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1652448148
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1652448148
Other Identifiers
ISSN
1021-335X
E-ISSN
1791-2431
DOI
10.3892/or.2014.3696
